TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DHR

Danaher Corporation

Healthcare · Diagnostics & Research

215.80$ +1.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow DHR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
18.9% 26.3% 20.9% 19.0% 23.6% 22.1% 27.9% 28.4% 32.0% 30.0% 28.0% 26.1%
4.7% 7.3% 6.7% 6.8% 7.7% 6.6% 8.0% 7.4% 8.3% 9.1% 9.9% 10.0%
0.6% 1.0% 0.8% 0.8% 0.9% 0.9% 0.8% 0.7% 1.3% 1.3% 1.2% 1.2%
1.5% -0.3% 0.8% -1.7% -0.2% 0.2% 1.1% 1.4% -0.8%
1.3% 0.4% -1.7% -1.9% -0.5% -0.7% 2.7% -2.2% -5.7% -1.6% 1.1% -2.9%
2.3% 3.6% 3.5% 3.1% 3.4% 3.5% 3.5% 4.4% 4.3% 5.8% 5.8% 4.7%
-17.3% -103.6% -31.1% -4.6% -17.3% -6.9% -95.3% -44.1% -8.4% -29.6% -8.3% -4.9%
1.1% 2.5% 2.4% 2.1% 2.5% 4.2% 2.8% 2.5% 3.1% 3.4% 3.2% 3.6%
1.4% -1.5% 14.8% 3.3% 2.4% 92.2% 25.6% 11.0% 3.5% 4.2% -25.0% -12.6%
-0.5% 63.5% 16.5% -14.5% -2.6% 74.5% -8.6% 7.0% -6.3% -6.8% -7.0% 4.3%
-1.1% 62.7% 12.1% -16.9% -4.7% 91.4% 4.5% 4.4% -9.6% -1.1% -35.1% -12.1%
-0.6% -15.3% 1.0% -1.8% 0.9% 106.8% -62.3% -11.7% 12.8% -0.5% -15.9% 10.3%
16.5% 22.8% 17.4% 15.9% 20.2% 18.5% 24.3% 24.0% 27.7% 24.2% 22.2% 21.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?